donanemab

Product

FDA-approved anti-amyloid monoclonal antibody for Alzheimer's disease, marketed as Kisunla

3 stories

Blood Test Identifies Dementia Risk in Women 25 Years Before Symptoms Emerge

Blood Tests Show Promise for Early Alzheimer's Detection

Simple Blood Test Can Predict Dementia 25 Years in Advance